In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Bausch Health Companies Inc (NYSE: BHC) closed the day trading at $8.71 up 1.04% from the previous closing price of $8.62. In other words, the price has increased by $1.04 from its previous closing price. On the day, 2.08 million shares were traded. BHC stock price reached its highest trading level at $8.82 during the session, while it also had its lowest trading level at $8.575.
Ratios:
For a better understanding of BHC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.11. For the most recent quarter (mrq), Quick Ratio is recorded 0.94 and its Current Ratio is at 1.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 20, 2023, Upgraded its rating to Buy and sets its target price to $16 from $9 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’24 when Carson Seana sold 6,313 shares for $9.80 per share. The transaction valued at 61,867 led to the insider holds 499,905 shares of the business.
Carson Seana sold 220 shares of BHC for $1,624 on Dec 05 ’23. The EVP, General Counsel now owns 382,925 shares after completing the transaction at $7.38 per share. On Nov 06 ’23, another insider, Carson Seana, who serves as the EVP, General Counsel of the company, sold 43 shares for $7.61 each. As a result, the insider received 327 and left with 384,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 3199871232 and an Enterprise Value of 25772738560. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36. Its current Enterprise Value per Revenue stands at 2.943 whereas that against EBITDA is 8.933.
Stock Price History:
Over the past 52 weeks, BHC has reached a high of $11.46, while it has fallen to a 52-week low of $5.57. The 50-Day Moving Average of the stock is -5.89%, while the 200-Day Moving Average is calculated to be 4.90%.
Shares Statistics:
Over the past 3-months, BHC traded about 2.82M shares per day on average, while over the past 10 days, BHC traded about 2626790 shares per day. A total of 365.24M shares are outstanding, with a floating share count of 356.59M. Insiders hold about 2.41% of the company’s shares, while institutions hold 78.99% stake in the company. Shares short for BHC as of 1713139200 were 20710888 with a Short Ratio of 7.34, compared to 1710460800 on 23776473. Therefore, it implies a Short% of Shares Outstanding of 20710888 and a Short% of Float of 7.489999999999999.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 6.52.
